These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 4154550)
1. Autochthonous grafts of spontaneous mammary tumors implanted together with allogeneic tissues. Tokuzen R; Nakahara W Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1974; 81(3-4):239-42. PubMed ID: 4154550 [No Abstract] [Full Text] [Related]
2. Suppression of autochthonous grafts of spontaneous mammary tumor by induced allogeneic graft rejection mechanism. Tokuzen R; Nakahara W Cancer Res; 1973 Apr; 33(4):645-7. PubMed ID: 4696465 [No Abstract] [Full Text] [Related]
3. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. Hibbs JB; Lambert LH; Remington JS J Infect Dis; 1971 Dec; 124(6):587-92. PubMed ID: 5127071 [No Abstract] [Full Text] [Related]
4. Growth of mouse mammary tumor related to host resistance. Takeuchi S; Uchida H Gan; 1971 Apr; 62(2):77-87. PubMed ID: 5114633 [No Abstract] [Full Text] [Related]
5. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors. BasombrÃo MA; Prehn RT Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598 [No Abstract] [Full Text] [Related]
6. Enhancement of the growth of sarcoma 180 in splenectomized and sham-operated AKR mice. Ferrer JF Transplantation; 1968 Mar; 6(2):160-6. PubMed ID: 5654084 [No Abstract] [Full Text] [Related]
8. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies. Rapp L; Fuji H Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755 [TBL] [Abstract][Full Text] [Related]
9. Effect of ethidium bromide against transplantable tumors in mice and rats. Kramer MJ; Grunberg E Chemotherapy; 1973 Oct; 19(4):254-8. PubMed ID: 4801160 [No Abstract] [Full Text] [Related]
10. Further studies on the protection by an F1 tumour against GvHR induced in F1 mice by injection of parental spleen cells. Palmer DB; Whitmarsh-Everiss T; Symes MO Br J Cancer; 1982 Aug; 46(2):300-3. PubMed ID: 7150479 [No Abstract] [Full Text] [Related]
11. Central inhibition of cellular immunity to leukemia L1210 by isoantibody. Mitchell MS Cancer Res; 1972 Apr; 32(4):825-31. PubMed ID: 4622583 [No Abstract] [Full Text] [Related]
13. Development of tumors as a result of graft-versus-host reaction. Cornelius EA Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858 [No Abstract] [Full Text] [Related]
14. Cancer immunity after treatment of Ehrlich tumor with diphtheria toxin. Buzzi S; Buzzi L Cancer Res; 1974 Dec; 34(12):3481-6. PubMed ID: 4429964 [No Abstract] [Full Text] [Related]
15. Further observations on whether host immunodepression is associated with tumour growth in mice. Rees JA; Symes MO Br J Cancer; 1971 Sep; 25(3):501-4. PubMed ID: 4401359 [TBL] [Abstract][Full Text] [Related]
16. Antigenic cross-reactivity between primary spontaneous mouse mammary tumors and their transplantable ascites tumors. Irie RF Cancer Res; 1971 Nov; 31(11):1682-9. PubMed ID: 4330634 [No Abstract] [Full Text] [Related]
17. A survey of the growth characteristics of and the host reactions to one hundred C3H/He mammary carcinomas. Vaage J Cancer Res; 1978 Feb; 38(2):331-8. PubMed ID: 620404 [No Abstract] [Full Text] [Related]
18. Modification of transplantability and tumor growth following treatment of L1210 leukemia and TA3Ha cells with macromomycin (NSC-170105). Lippman MM; Abbott BJ Cancer Chemother Rep; 1973; 57(4):501-3. PubMed ID: 4762442 [No Abstract] [Full Text] [Related]
19. Enhancement of tumor growth by graft-versus-host reaction. Okubo S; Oettgen HF; Caiazza SS; Ovary Z Proc Natl Acad Sci U S A; 1974 Oct; 71(10):4264-6. PubMed ID: 4154441 [TBL] [Abstract][Full Text] [Related]
20. The immune recognition of TA3 tumors, its facilitation by endotoxin, and abrogation by ascites fluid. Grohsman J; Nowotny A J Immunol; 1972 Nov; 109(5):1090-5. PubMed ID: 4562425 [No Abstract] [Full Text] [Related] [Next] [New Search]